We're Working on Better Science to Treat Brain Disease
The Roskamp Institute is devoted to understanding causes and finding treatments for brain disorders.
From Our Executive Director
“The next few years are going to be very critical in our understanding of Alzheimer’s Disease and consequently for our search for new treatments.”
Who We Are
We are a world renowned team of experts from all over the world working tirelessly on our research.
Staff members of the Institute have offered educational presentations throughout the Sarasota and Manatee areas, and are ready to do so for your group or facility.
The Roskamp Institute has been working on novel treatments and research for Alzheimer’s, PTSD, TBI, and other brain diseases for over 10 years.
You can join our elite group of Alumni with a Ph.D in neuroscience, with real world training at our facility in Sarasota.
Our Mission & Vision
The mission of The Roskamp Institute is to conduct scientific research to discover safe and effective new drug therapies to treat diseases of the mind and to promote healthy aging.
Headed by Drs. Michael Mullan and Fiona Crawford, the Institute employs experienced scientists and technicians and houses state-of-the-art research labs and equipment to conduct scientific research. The quality of research performed at the Institute reflects our motto: Better science. Real discovery.
Video: Our Research Impact
For over two decades Roskamp Institute scientists have studied the causes and potential cures for neurological disorders such as Alzheimer’s Disease (AD), including the link between environmental agents and increased risk for AD and other brain conditions. So when...
During these challenging times, as well as taking many precautions at the Roskamp Institute to keep the laboratories and clinic functioning to serve our patients and keep the research advancing, we are paying special interest to the central nervous system aspects of...
New Roskamp Institute Clinical Research Shows Promise of Drug to Slow Early-stage Alzheimer’s Disease
Sarasota, Fla.— New data from a clinical trial of Alzheimer’s Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer’s disease show less cognitive decline over an...
The Roskamp Institute has a full service Neurology clinic located on-premise. There, we apply our cutting-edge research and partner with experts in the industry to provide the highest level of patient care for all. To learn more, visit the clinic website: RoskampClinic.org